Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350
June 21 2005 - 9:01AM
PR Newswire (US)
Biosite(R) Incorporated Reports New Option Grants Under NASDAQ
Market Rule 4350 SAN DIEGO, June 21 /PRNewswire-FirstCall/ --
Biosite Incorporated (NASDAQ:BSTE), today announced that, in
accordance with NASDAQ Marketplace Rule 4350, 23 non-officer
employees were granted inducement stock options covering an
aggregate of 23,900 shares of common stock. These options were
granted pursuant to NASDAQ Marketplace Rule 4350 (i)(1)(A)(iv) with
the following terms: each option has been classified as a
non-qualified stock option, has an exercise price equal to the fair
market value on the grant date, has a ten-year term, and vests in
16 equal quarterly installments over four years (on each quarterly
anniversary of the applicable vesting commencement date). About
Biosite Incorporated Biosite Incorporated is a leading bio-medical
company commercializing proteomics discoveries for the advancement
of medical diagnosis. The Company's products contribute to
improvements in medical care by aiding physicians in the diagnosis
of critical diseases and health conditions. Biosite's Triage(R)
rapid diagnostics are used in approximately 50 percent of U.S.
hospitals and in over 50 international markets. Information on
Biosite can be found at http://www.biosite.com/. Biosite(R)
Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a
trademark of Biosite Incorporated. DATASOURCE: Biosite Incorporated
CONTACT: Nadine Padilla, Vice President, Corporate & Investor
Relations of Biosite Incorporated, +1-858-455-4808, ext. 3187, Web
site: http://www.biosite.com/ Company News On-Call:
http://www.prnewswire.com/comp/116737.html
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024